Biological compatibility and micromorphologic observation of three dimensional porous beta-tricalcium phosphate scaffolds and mesenchymal stem cells in constructing tissue engineered bone

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 11, Issue 9, 2007, Pages 1640-1643

  Cheng, Xiao Bing ^a   Ma, Qin ^a   Hou, Rui ^a   Yang, Y W ^a   Mao, T Q ^a   Ao, J H ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BONE TISSUE; CELL PROLIFERATION; COCULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; INOCULATION; MESENCHYMAL STEM CELL; MICROMORPHOLOGY; NONHUMAN; OSTEOBLAST; POROSITY; RABBIT; SCANNING ELECTRON MICROSCOPE; TISSUE ENGINEERING;

EID: 34250333818     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chinese source.
2. El-Ghannam A. Bone reconstruction: from bioceramics to tissue engineering. Expert Rev Med Devices 2005;2(1):87-101
3. Yamada Y, Ueda M. Regenerative medicine for bone using mesenchymal stem cells. Nippon Ronen Igakkai Zasshi 2006;43 (3): 338-341
4. Chinese source.
5. Chinese source.
6. Chinese source.
7. Rai B, Teoh SH, Ho KH, et al. The effect of rhBMP-2 on canine osteoblasts seeded onto 3D bioactive polycaprolactone scaffolds. Biomaterials 2004;25(24):5499-5506
8. Vacanti CA, Bonassar LJ. An overview of tissue engineered bone. Clin Orthop Relat Res 1999;(367 Suppl):S375-S381
9. Jadlowiec JA, Celil AB, Hollinger JO. Bone tissue engineering: recent advances and promising therapeutic agents.Expert Opin Biol Ther 2003; 3(3):409-423
10. Chinese source.
11. Burg KJ, Poder S, Kellam JF. Biomaterial developments for bone tissue engineering. Biomaterials 2000;21(23):2347-2359
12. Mauney JR, Kirker-Head C, Abrahamson L, et al. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. J Biomed Mater Res A 2006;79(3)464-475
13. Vidal MA, Kilroy GE, Johnson JR, et al. Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg 2006;35(7):601-610
14. Kishimoto M, Kanemaru S, Yamashita M, et al. Cranial bone regeneration using a composite scaffold of Beta-tricalcium phosphate, collagen, and autologous bone fragments. Laryngoscope 2006; 116(2):212-216
15. Chinese source.
16. Choong CS, Hutmacher DW, Triffitt JT. Co-culture of bone marrow fibroblasts and endothelial cells on modified polycaprolactone substrates for enhanced potentials in bone tissue engineering. Tissue Eng 2006;12 (9):2521-2531
17. Chinese source.
18. Chinese source.
19. Gronthos S, Akintoye SO, Wang CY, et al. Bone marrow stromal stem cells for tissue engineering. Periodontol 2000 2006;41:188-195
20. Kemp KC, Hows J, Donaldson C. Bone marrow-derived mesenchymal stem cells. Leuk Lymphoma 2005;46(11):1531-1544